Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [HEALTH]
2 clusters · 4 sources · 14 days · First seen · Last updated
Seoul St. Mary's Hospital hematology advancements
Overview
Seoul St. Mary's Hospital has made several advancements in hematology and medical management. The hospital implemented a self-developed automated software system designed to manage the Risk Management Program (RMP) for specific anticancer drugs, such as thalidomide and lenalidomide. This system aims to reduce administrative burdens on medical staff by automating patient data retrieval while maintaining safety through a double-approval structure and internal network security.
Additionally, the hospital’s Hematology Hospital received eight awards at the 2026 International Conference on Hematopoietic Stem Cell Transplantation (ICBMT 2026). Research presented by the institution covered various topics, including the analysis of Belumosudil for chronic graft-versus-host disease, treatment alternatives for patients failing CAR-T therapy, and the efficacy of CAR-T therapy in pediatric leukemia. Other studies addressed precision dosing for anti-thymocyte globulin and the effectiveness of autologous stem cell transplantation in elderly patients.
Entities
Seoul St. Mary's Hospital · ICBMT 2026 · Jae-ho Yoon · Min Chang-ki · Lee Jeong-yeon
Timeline
-
[HEALTH] 3 sourcesSeoul St. Mary's Hospital wins multiple awards at ICBMT 2026
Seoul St. Mary's Hospital Hematology Hospital won eight awards at ICBMT 2026, presenting research on CAR-T therapy, precision dosing, and improved transplant strategies for blood diseases.
-
[HEALTH] 2 sourcesSeoul St. Mary's Hospital implements automated anticancer drug management system
Seoul St. Mary's Hospital has deployed a custom automated system to streamline the Risk Management Program for anticancer drugs, reducing medical staff workload while enhancing prescription safety.
Sources
bokuennews.com · bosa.co.kr · healthmedia.co.kr · hin.company